Tred Avon Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Buy
21,579
+3,568
+20% +$208K 0.43% 55
2025
Q4
$971K Sell
18,011
-569
-3% -$27.4K 0.32% 80
2025
Q3
$838K Buy
+18,580
New +$868K 0.29% 96

Other funds holding BMY

Tred Avon Family Wealth's BMY Position: Q1 2026 in Review

Tred Avon Family Wealth increased its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, buying an estimated $208K and bringing the position to 21,579 shares worth $1.31M. The position accounts for 0.43% of the portfolio, ranked #55.

Tred Avon Family Wealth first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tred Avon Family Wealth held 21,579 shares of Bristol-Myers Squibb worth $1.31M as of Q1 2026.
  • Tred Avon Family Wealth bought 3,568 Bristol-Myers Squibb shares in Q1 2026, an estimated $208K.
  • Bristol-Myers Squibb made up 0.43% of Tred Avon Family Wealth's portfolio in Q1 2026, its #55 holding.
  • Tred Avon Family Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tred Avon Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.